Lundbeck
Global pharmaceutical company focused exclusively on brain health, including neurological and psychiatric disorders.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Chronic Migraine in Children
A Study of Eptinezumab in Pediatric Participants With Episodic MigrainePhase 3 · Recruiting · Episodic Migraine
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigrainePhase 3 · Recruiting · Migraine
A Trial of Lu AG13909 in Adult Participants With Cushing's DiseasePhase 2 · Recruiting · Cushing's Disease
A Trial of Lu AG13909 in Participants With Congenital Adrenal HyperplasiaPhase 1 · Recruiting · Congenital Adrenal Hyperplasia
A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have NarcolepsyPhase 1 · Recruiting · Narcolepsy
Selected patent records
brexpiprazole · Expires 2026-04-12
US 8618109brexpiprazole · Expires 2026-04-12
US 9839637brexpiprazole · Expires 2026-04-12
US 8349840*PEDbrexpiprazole · Expires 2026-10-12
US 8618109*PEDbrexpiprazole · Expires 2026-10-12
US 9839637*PEDbrexpiprazole · Expires 2026-10-12
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/lundbeck/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.